Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
 
The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research
ISPOR CORNER

ISPOR 11th Annual European Congress Scientific Awards Recipients

Stephen Priori, Director, ISPOR Publications

The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year's European Congress, the ISPOR Awards Committee evaluated approximately 76 podium presentations and over 900 poster presentations.

SCIENTIFIC AWARD RECIPIENTS

BEST CONTRIBUTED PODIUM AWARDS PRESENTATIONS

HT3 A COMPARISON OF REASONS FOR RECOMMENDATION AND REJECTION IN FOUR HEALTH TECHNOLOGY APPRAISAL SYSTEMS: NICE, SMC, CADTH AND PBAC
Cann K, Karia R, Plested M, Samuels E, Zwaferink H, Heron Evidence Development Ltd, Letchworth Garden City, UK

MO2 INCORPORATING CALIBRATED MODEL PARAMETERS INTO SENSITIVITY ANALYSES: DETERMINISTIC AND PROBABILISTIC APPROACHES
Taylor DC1, Kruzikas D2, Pawar V3, Gilmore K1, Naik S1, Weinstein MC4, 1i3 Innovus, Medford, MA, USA, 2GlaxoSmithKline, Philadelphia, PA, USA, 3Innovus Research, Inc, Medford, MA, USA, 4i3 Innovus Research Inc., Harvard School of Public Health, Harvard Medical School, Boston, MA, USA

MS3 POPULATION HEALTH-STATE UTILITIES FOR FIBROMYALGIA IN THE UK
Hauber AB1, McCrink L2, Beard S2, Garcia-Cebrian A3, Maas G4, Das Gupta R5, Le TK6, 1RTI Health Solutions, Research Triangle Park, NC, USA, 2RTI Health Solutions, Manchester, UK, 3Eli Lilly and Company Limited, Basingstoke, UK, 4Boehringer Ingelheim GmbH, Ingelheim, Germany, 5Boehringer Ingelheim, Bracknell, Berkshire, UK, 6Eli Lilly and Company, Indianapolis, IN, USA

 

BEST NEW INVESTIGATOR POSTER AWARDS PRESENTATIONS

PCN6 MODELING LUNG AND BREAST CANCER INCIDENCE IN SPAIN: A ZERO INFLATED NEGATIVE BINOMIAL REGRESSION APPROACH
Villa G, Cuervo J, Rebollo P, BAP Health Outcomes Research, Oviedo, Asturias, Spain

PCN21 COST-EFFECTIVENESS OF LAPATINIB PLUS CAPECITABINE FOR WOMEN WITH HER2+ METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH TRATSTUZUMAB IN FINLAND
Färkkilä N1, Torvinen S1, Bergius S1, Delea T2, Sofrygin O2, Walker M3, 1GlaxoSmithKline Oy, Espoo, Finland, 2Policy Analysis Inc. (PAI), Brookline, MA, USA, 3GlaxoSmithKline, London, UK

PCN67 COST UTILITY ANALYSIS OF ALEMTUZUMAB COMPARED TO CHLORAMBUCIL IN UNTREATED PATIENTS WITH HIGH-RISK (17P-) CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED KINGDOM
Lloyd AC1, Valderrama A2, Ferguson J3, Gilmour L3, Ravndal F1, 1IMS, London, UK, 2Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA, 3Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, UK

     

BEST NEW INVESTIGATOR PODIUM AWARDS PRESENTATIONS
AR3 TO INVESTIGATE THE BENEFIT OF ANTI-TNF THERAPY ON PHYSICAL AND MENTAL FUNCTIONING VIA THE SHORT FORM-36 QUALITY OF LIFE QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Adams R1, Ng CT2, Gibbs A3, Bresnihan B4, Veale D5, Tilson L1, FitzGerald O5, Barry M1, 1National Centre for Pharmacoeconomics, Dublin, Ireland, 2St.Vincents University, Dublin, Ireland, 3Galway Clinic, Galway, Ireland, 4St. Vincents University Hospital, Dublin, Ireland, 5St.Vincents University Hospital, Dublin, Ireland

CN6 COST-EFFECTIVENESS OF A HUMAN PAPILLOMAVIRUS VACCINE IN REDUCING THE RISK OF CERVICAL CANCER IN IRELAND USING A TRANSMISSION DYNAMIC MODEL
Usher C1, Tilson L1, Olsen J2, Rudbeck Jepsen M3, Walsh C4, Barry M1, 1National Centre for Pharmacoeconomics, Dublin, Ireland, 2University of Southern Denmark, Odense, Denmark, 3Statens Serum Institut, DK-2300 Copenhagen S, Denmark, 4Trinity College Dublin, Dublin, Ireland

MH2 THE SUSTAINED DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM CHILDHOOD TO ADULTHOOD: A MEDICAID STUDY
Chen H, Sudharshan L, University of Houston, Houston, TX, USA

 

BEST STUDENT POSTER AWARDS PRESENTATIONS

PDB65 A COMPARISON OF DIABETES KNOWLEDGE AMONG RESIDENTS IN BANGKOK AND OTHER CENTRAL PROVINCES OF THAILAND
Pongmesa T1, Li SC2, Wee HL1, 1National University of Singapore, Singapore, 2University of Newcastle, Callaghan, Australia

PND3 ANTI-EPILEPTIC MEDICATION DRUG FORMULATION CHANGES AND THEIR RELATIONSHIP TO OUTCOMES (AMBULANCE, EMERGENCY DEPARTMENT AND INPATIENT EVENTS
Mann TA, Rascati KL, Richards KM, Johnsrud M, The University of Texas at Austin, Austin, TX, USA

PSY62 A NATURAL EXPERIMENT TO ESTIMATE THE IMPACT OF A PREFERRED DRUG LIST POLICY FOR LONG ACTING NARCOTIC ANALGESICS ON COSTS AND UTILIZATION
Flannagin KR, Martin BC, University of Arkansas for Medical Sciences, Little Rock, AR, USA

     

BEST STUDENT PODIUM AWARD PRESENTATION

MH7 PATIENT REPORTED OBJECTIVES AND PRIORITIES FOR THE TREATMENT OF SCHIZOPHRENIA IN GERMANY: A MIXED METHODS APPROACH TO CAPTURING THE PATIENT'S PERSPECTIVE
Kinter ET1, Rudolph I2, Schmeding A2, Bridges JF1, 1Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA, 2Janssen-Cilag GmbH, Neuss, Germany

 

ISPOR ANNUAL EUROPEAN CONGRESS RESEARCH AWARDS CHAIRS:
Podium: Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health (UMIT), Adjunct Professor of Health Policy and Management (Harvard School of Public Health); Chair of Department of Public Health, Medical Decision Making and Health Technology; University of Health Sciences, Medical Informatics and Technology; Hall/Innsbruck, Austria
Poster: Evi Hatziandreou MD, DrPH, Director, Health and Healthcare, RAND Europe, Cambridge, UK

A special thanks goes to all the judges, the ISPOR Annual European Congress
Research Awards Chairs as well as the ISPOR Awards Committee Chair who volunteered
their time and efforts in selecting the winners.

     

BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS

PIN24 ECONOMIC AND CLINICAL IMPACT OF IMPLEMENTATION OF AN ACELLULAR PERTUSSIS VACCINE IN CANADA
Iskedjian M1, Walker J1, De Serres G2, Einarson TR1, 1PharmIdeas Research and Consulting Inc, Oakville, ON, Canada, 2Université Laval, Québec, QC, Canada

PMS47 USING HAQ TO ESTIMATE HUI3 AND EQ-5D UTILITY VALUES IN SPANISH RHEUMATOID ARTHRITIS PATIENTS
Fernández I1, Varela C1, Layola M2, Ruiz MD3, Navarro F3, 1Roche Farma, Madrid, Spain, 2IMS Health, Barcelona, Spain, 3Hospital Universitario Virgen Macarena, Sevilla, Spain

PSY33 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH BLOOD TRANSFUSION DURING INPATIENT HOSPITALIZATION: AN ANALYSIS OF THE 2004 HEALTH CARE COST AND UTILIZATION PROJECT NATIONWIDE INPATIENT SAMPLE DATABASE
Patel ST1, Anastassopoulos K1, Lerner J1, Ryan K1, Dodd SL2, Goss TF1, Morton J3, 1Covance Market Access Services, Gaithersburg, MD, USA, 2Ethicon, Inc, Silesia, MT, USA, 3Stanford University School of Medicine, Stanford, CA, USA

 

ISPOR JUDGES:

Christos Chouaid, Clark Paramore, Carole Coudray Omnes, John Bridges, Carl Asche, Laura McCullagh, Denis Getsios, Brett Hauber, Michael Iskedjian, Gabriela Tannus, Ian Johnson, Katy Slack, Matthew Treaney, Birgitta von Scheele, Lauren Lent, Donald Bushnell, Karen Rascati, Rajesh Balkrishnan, Kristen Migliaccio, Robert Plisko, Deborah Lubeck, Joice Valentim, Ljubica Besker, Hiltrud Liedgens, Mohammad Addollahi, Kirsten Long, Adele Weston, Axel Muhlbacher, Bernard Selke, Sinisa Antolic, Hsing Yi, Matthieu Cuche, Erwin De Cock, Lee Moore, Erna, Ribnicsek, Christel Naujoks, Katalin Rapi, Tony Eti-ukwu, Tipaporn Pongmesa, Michael Minshall, Meir Oren, Nikfar Sheloufeh, Jan Sabo, Beth O'Leary, Zahra Pourmoghaddas, Michael Ganz, Barbara Poulsen-Nautrup, Victoria Brennan, Bradley Martin, Samuel Wagner, Elli Vitsou, Mario Stegert, Siew Hwa Ong, Janneke Grutters, Anna Vavrovsky, Lynda Doward, Hicham Benhaddi, Fleur Levrat, Anne Solesse, Patrick Mollon, Iwona Skrekowska-Baran, Su-Fen Tsai, Chuong Ho, Ahmed Al-Ansi, James Palmer, Yajaira Bastardo, Floortje VanNooten


  Issues Index | 2008 Issues Index  

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.